What is uniQure N.V. (QURE)?
uniQure N.V. is a biotechnology company specializing in gene therapy. The company focuses on developing and commercializing innovative treatments for patients with severe genetic diseases. Its research and development efforts primarily target areas such as hemophilia, Huntington's disease, and other rare disorders. uniQure utilizes adeno-associated virus (AAV) vector technology to deliver therapeutic genes to patients. Headquartered in the Netherlands, the company operates globally with a presence in the United States and Europe. uniQure collaborates with academic institutions and industry partners to advance its pipeline. The company also engages in manufacturing of gene therapy products, maintaining control over critical aspects of production. Its portfolio includes both proprietary and partnered programs aimed at addressing unmet medical needs through genetic medicine.
uniQure N.V. Stock Price Today: Live Overview
The price today is shaped by ongoing market activity, with Banc of California Inc currently at $15.73. It has fluctuated between $15.51 and $16.08, showing a daily change of -3.924%.
FAQ: uniQure N.V. (QURE)
What is the current price of QURE stock?
The last recorded price for uniQure N.V. is $15.73.
Does QURE pay dividends?
uniQure N.V. pays dividends via cash distributions (if applicable).
Does QURE have a formal corporate presence or regional headquarters in the UAE?
uniQure N.V. operates in the UAE through partners and distributors without an official regional office or subsidiary.
What is QURE best known for?
uniQure N.V. is most famous for its gene therapy products.
What assets are typically shown together with QURE?
Commonly shown alongside QURE: China Everbright, Tradr 1X Short Innovation Daily ETF, DNOW Inc
Latest shares articles



